# Full-scale Intervention Study: Genetic Risk Communication and Wearables

Study · id `cardio:ct-nct05524909` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05524909](<https://clinicaltrials.gov/study/NCT05524909>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05524909

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 355 participants.

## Technical summary

Registry record NCT05524909. Randomized; double masking; primary purpose prevention. Start 2022-11-01 (actual); primary completion 2025-04-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 355 participants (enrolled count; ClinicalTrials.gov record NCT05524909, source copy `cardio:ctgov-nct05524909-2026-05-04`, retrieved 2026-10-26)
- Started: 2022-11-01 (actual) (ClinicalTrials.gov record NCT05524909, source copy `cardio:ctgov-nct05524909-2026-05-04`, retrieved 2026-10-26)
- Primary completion: 2025-04-30 (actual) (ClinicalTrials.gov record NCT05524909, source copy `cardio:ctgov-nct05524909-2026-05-04`, retrieved 2026-10-26)
- Completion: 2025-06-30 (actual) (ClinicalTrials.gov record NCT05524909, source copy `cardio:ctgov-nct05524909-2026-05-04`, retrieved 2026-10-26)
- Countries: Hong Kong SAR China (ClinicalTrials.gov record NCT05524909, source copy `cardio:ctgov-nct05524909-2026-05-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05524909-2026-05-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Full-scale Intervention Study: Genetic Risk Communication and Wearables
- Condition: Fitness Trackers
- Condition: Physical Activity
- Condition: Exercise
- Condition: Genetic Predisposition to Disease
- Condition: Type 2 Diabetes
- Intervention (Genetic): Genetic Risk Estimate
- Intervention (Device): Genetic Risk Estimate + Fitbit Functions
- Lead sponsor: The University of Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: The University of Hong Kong (`cardio:org-the-university-of-hong-kong`)

## Provenance

Content hash: a86651e18340a67fd1ba944ce1d842d32c44d4d2bacb5dbf7aeabaac36a3bd95
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
